Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease.

Korte N, Nortley R, Attwell D. · 2020

Read Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease. by Korte N, Nortley R, Attwell D. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7666276.txt.

Description

Korte and co-authors argue that reduced brain blood flow is an early driver of Alzheimer disease. Drugs aimed at late events, such as amyloid and tau clumps, have mostly failed in trials. The authors point to blood flow as the earliest sign seen on biomarkers.

Small vessels narrow when support cells called pericytes contract, likely in response to amyloid fragments. Trapped white blood cells and clots cut flow further. Low flow then boosts the enzyme that makes amyloid and drives tau change. The authors urge treatments aimed at this early step rather than at late damage alone.

Catalog record

CREATORKorte N, Nortley R, Attwell D.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE87 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7666276

Browse the full library · About the Tower of Babel